Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Tissue Heart Valves Market Set for Growth Through 2034, Driven by Aging Populations, Innovation in Valve Technologies, and Rising Demand for Minimally Invasive Cardiac Procedures

globenewswire.com
ABT Abbott is listed as a prominent company operating in the tissue heart valves market, which is projected for significant growth. The article does not provide specific sentiment towards Abbott's performance or products. BSX Boston Scientific Corporation is identified as a prominent player in the growing tissue heart valves market. The article highlights market growth drivers and technological advancements relevant to the company's sector, but offers no specific sentiment for BSX. CYTK CryoLife is mentioned as a company operating in the tissue heart valves market, which is expected to grow. The article provides a general market outlook and competitive landscape but no specific sentiment for CryoLife. EW Edwards Lifesciences is highlighted with specific positive developments, including FDA approval for its EVOQUE Tricuspid Valve Replacement System and the European launch of its SAPIEN 3 Ultra RESILIA valve. The company also launched a next-generation transcatheter heart valve in India. These indicate strong market positioning and product innovation. MDT Medtronic is listed as a prominent company in the tissue heart valves market, which is experiencing growth. The article discusses market drivers and competitive landscape but does not offer specific sentiment for Medtronic. LIVN LivaNova PLC (Sorin Group) is mentioned as a company operating in the tissue heart valves market. The article provides a general market outlook and competitive landscape but no specific sentiment for LivaNova.

Tissue Heart Valves Market Set for Growth Through 2034, Driven by Aging Populations, Innovation in Valve Technologies, and Rising Demand for Minimally Invasive Cardiac Procedures Dublin, Sept. 17, 2026 (GLOBE NEWSWIRE) -- "Tissue Heart Valves - Market Insights, Competitive Landscape, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's offering.

Global Tissue Heart Valves Market to Reach USD 25.30 Billion by 2034 as Transcatheter Procedures Accelerate

The global tissue heart valves market is projected to expand from USD 10.74 billion in 2025 to USD 25.30 billion by 2034, registering a compound annual growth rate of 10.08% from 2026 to 2034. Market growth is being supported by the rising prevalence of valvular heart disease, increasing demand for minimally invasive cardiac procedures, technological advances in valve durability, and expanding access to specialized cardiovascular care.

Key Tissue Heart Valves Market Growth Drivers

Aortic stenosis and mitral regurgitation remain major contributors to the growing demand for tissue heart valve replacement. The incidence of these conditions rises substantially with age, creating a significant treatment need among expanding elderly populations worldwide. Tissue valves are frequently selected for older patients because they generally reduce the need for lifelong anticoagulation therapy compared with mechanical alternatives.

The rapid adoption of transcatheter aortic valve replacement and implantation procedures, commonly known as TAVR or TAVI, is another significant market driver. Expansion into intermediate- and low-risk patient populations has increased procedure volumes, while shorter hospital stays, faster recovery, and reduced surgical risks have strengthened adoption. Emerging transcatheter mitral and tricuspid valve replacement technologies are also broadening the long-term market opportunity.

Product innovation is improving tissue valve performance and expanding treatment eligibility. Anti-calcification technologies, advanced leaflet designs, sutureless surgical valves, next-generation delivery systems, and valve-in-valve procedures are helping enhance durability and procedural outcomes. These developments may also increase physician confidence in treating younger and lower-risk patients.

Market Segmentation Highlights

The tissue heart valves market is segmented by type, valve position, end user, and geography. By type, the market includes stented, stentless, and sutureless valves, with the stented category estimated to hold the largest market share in 2025. Valve positions covered include aortic, mitral, pulmonary, and tricuspid valves.

Major end users include hospitals, ambulatory surgical centers, and cardiac specialty centers. Hospitals are expected to remain important treatment settings because of their advanced imaging capabilities, multidisciplinary cardiac teams, intensive care resources, and ability to perform both surgical and transcatheter valve procedures.

Regional Tissue Heart Valves Market Outlook

North America is expected to lead the global tissue heart valves market, accounting for approximately 38% of revenue in 2025. The region benefits from a high prevalence of valvular heart disease, widespread adoption of TAVR, favorable reimbursement frameworks, established cardiac care infrastructure, and the presence of leading medical device manufacturers. Research indicates that more than 13% of Americans aged 75 and older are affected by aortic stenosis, supporting sustained demand for surgical and transcatheter valve replacement.

Regulatory approvals and product development are further strengthening the North American market. In February 2024, the U.S. Food and Drug Administration approved the Edwards EVOQUE Tricuspid Valve Replacement System, expanding transcatheter treatment options for eligible patients with tricuspid valve disease.

Europe remains a major contributor to tissue heart valves market growth because of its aging population, substantial burden of valvular heart disease, advanced hospital infrastructure, supportive reimbursement systems, and strong clinical research activity. In May 2024, Edwards Lifesciences announced the European launch of the SAPIEN 3 Ultra RESILIA valve following CE Mark authorization. The product incorporates RESILIA tissue technology and is intended to support improved long-term valve durability.

Asia-Pacific is anticipated to record significant growth as China, India, Japan, South Korea, and Australia expand access to advanced cardiac treatment. Rising healthcare investment, improving hospital infrastructure, supportive public health initiatives, and increasing adoption of minimally invasive procedures are creating new opportunities. In September 2025, Edwards Lifesciences launched a next-generation transcatheter heart valve in India for the treatment of aortic stenosis, reflecting growing demand for TAVR across emerging markets.

Competitive Landscape

The tissue heart valves market features established multinational medical device companies alongside emerging regional manufacturers. Leading companies use extensive research and development capabilities, clinical evidence, broad product portfolios, regulatory expertise, and global distribution networks to maintain their competitive positions. Regional manufacturers are gaining traction by developing cost-competitive products tailored to local healthcare requirements.

Prominent companies operating in the tissue heart valves market include:

Competition is expected to intensify through product launches, clinical trials, strategic partnerships, mergers, acquisitions, and investment in valve durability. Companies that can demonstrate improved long-term performance, simplified implantation, broader clinical indications, and competitive pricing are likely to be well positioned for future growth.

Artificial Intelligence and Digital Innovation

Artificial intelligence is influencing tissue heart valve research, product design, patient selection, and procedural planning. Machine learning can analyze imaging, anatomical, biomechanical, and clinical data to support valve sizing and identify patient-specific risks. AI-enabled computational modeling also allows developers to simulate valve performance under varied physiological conditions, potentially reducing development timelines and improving prototype evaluation.

Within clinical settings, AI-supported imaging and navigation may enhance procedural precision during transcatheter implantation. Predictive analytics are also being investigated for monitoring calcification, structural valve degeneration, and other long-term complications. These capabilities could support more personalized treatment decisions and earlier intervention.

Market Challenges and Trade Considerations

Despite a positive outlook, tissue heart valve market growth may be constrained by structural valve degeneration and calcification, particularly among younger patients who may require future intervention. The high cost of TAVR and other advanced procedures can also restrict access in cost-sensitive markets. Lengthy regulatory reviews, extensive clinical trial requirements, and the need for long-term safety evidence increase development expenses and may delay commercialization.

U.S. tariffs affecting medical devices, imported materials, and components may create additional cost and supply-chain pressures. Manufacturers could respond by diversifying suppliers, expanding regional production, renegotiating contracts, or adjusting pricing strategies. Hospitals and healthcare providers may also face higher procurement costs if tariff-related expenses are transferred across the value chain.

Report Scope and Strategic Value

The tissue heart valves market report evaluates current market size, forecasts through 2034, competitive developments, regulatory conditions, product innovation, and regional opportunities. It examines stented, stentless, and sutureless valves across aortic, mitral, pulmonary, and tricuspid applications. Geographic coverage includes North America, Europe, Asia-Pacific, South America, the Middle East, and Africa.

The analysis supports manufacturers, investors, healthcare organizations, and other market participants in identifying high-growth segments, evaluating competitive positioning, planning market-entry strategies, managing supply-chain risks, and assessing opportunities created by minimally invasive cardiac procedures. With TAVR adoption continuing to expand and manufacturers investing in next-generation valve technologies, the global tissue heart valves market is expected to maintain strong growth through 2034.

Key Topics Covered:

1. Tissue Heart Valves Market Report Introduction

1.1 Scope of the Study

1.2 Market Segmentation

1.3 Market Assumption

2. Tissue Heart Valves Market Executive Summary

2.1 Market at Glance

3. Tissue Heart Valves Market Key Factors Analysis

3.1 Tissue Heart Valves Market Drivers

3.1.1 Rising Prevalence of valvular heart diseases leading to a surge in tissue heart valves

3.1.2 Rapid growth of Transcatheter Valve Procedures (TAVR/TAVI) escalating the market of tissue heart valves

3.1.3 Increase in technological advancement

3.2 Tissue Heart Valves Market Restraints and Challenges

3.2.1 Limited durability and risk of calcification

3.2.2 Stringent regulatory process for product approval

3.3 Tissue Heart Valves Market Opportunity

3.3.1 Integration of advanced imaging, AI-driven diagnostics, and robotic assistance

4. Impact Analysis

4.1 AI-Powered Innovations and Applications

4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

5.1 The United States

5.2 Europe

5.3 Japan

5.4 China

6. Tissue Heart Valves Market Porter's Five Forces Analysis

6.1 Bargaining Power of Suppliers

6.2 Bargaining Power of Consumers

6.3 Threat of New Entrants

6.4 Threat of Substitutes

6.5 Competitive Rivalry

7. Tissue Heart Valves Market Assessment

7.1 By Type

7.1.1 Stented

7.1.2 Stentless

7.1.3 Sutureles

7.2 By Valve Position

7.2.1 Aortic Valve

7.2.2 Mitral Valve

7.2.3 Pulmonary Valve

7.2.4 Tricuspid Valve

7.3 By End-Users

7.3.1 Hospitals

7.3.2 Ambulatory Surgical Centers

7.3.3 Cardiac Specialty Centers

7.4 By Geography

7.4.1 North America

7.4.1.1 United States Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.1.2 Canada Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.1.3 Mexico Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.2 Europe

7.4.2.1 France Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.2.2 Germany Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.2.3 United Kingdom Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.2.4 Italy Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.2.5 Spain Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.2.6 Rest of Europe Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.3 Asia-Pacific

7.4.3.1 China Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.3.2 Japan Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.3.3 India Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.3.4 Australia Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.3.5 South Korea Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.3.6 Rest of Asia-Pacific Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.4 Rest of the World (RoW)

7.4.4.1 Middle East Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.4.2 Africa Tissue Heart Valves Market Size in USD million (2023-2034)

7.4.4.3 South America Tissue Heart Valves Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Tissue Heart Valves Market Company and Product Profiles

10.1 Abbott

10.1.1 Company Overview

10.1.2 Company Snapshot

10.1.3 Financial Overview

10.1.4 Product Listing

10.1.5 Entropy

10.2 Boston Scientific Corporation

10.2.1 Company Overview

10.2.2 Company Snapshot

10.2.3 Financial Overview

10.2.4 Product Listing

10.2.5 Entropy

10.3 CryoLife

10.3.1 Company Overview

10.3.2 Company Snapshot

10.3.3 Financial Overview

10.3.4 Product Listing

10.3.5 Entropy

10.4 Edward Lifesciences Corporation

10.4.1 Company Overview

10.4.2 Company Snapshot

10.4.3 Financial Overview

10.4.4 Product Listing

10.4.5 Entropy

10.5 Medtronic

10.5.1 Company Overview

10.5.2 Company Snapshot

10.5.3 Financial Overview

10.5.4 Product Listing

10.5.5 Entropy

10.6 Sorin Group (LivaNova PLC)

10.6.1 Company Overview

10.6.2 Company Snapshot

10.6.3 Financial Overview

10.6.4 Product Listing

10.6.5 Entropy

10.7 Braile Biomedica and Labcor Laboratorios

10.7.1 Company Overview

10.7.2 Company Snapshot

10.7.3 Financial Overview

10.7.4 Product Listing

10.7.5 Entropy

10.8 Colibri Heart Valve

10.8.1 Company Overview

10.8.2 Company Snapshot

10.8.3 Financial Overview

10.8.4 Product Listing

10.8.5 Entropy

10.9 ON-X LIFE TECHNOLOGIES

10.9.1 Company Overview

10.9.2 Company Snapshot

10.9.3 Financial Overview

10.9.4 Product Listing

10.9.5 Entropy

10.10 JenaValve Technology Inc.

10.10.1 Company Overview

10.10.2 Company Snapshot

10.10.3 Financial Overview

10.10.4 Product Listing

10.10.5 Entropy

10.11 TTK Healthcare Limited

10.11.1 Company Overview

10.11.2 Company Snapshot

10.11.3 Financial Overview

10.11.4 Product Listing

10.11.5 Entropy

10.12 Comed BV

10.12.1 Company Overview

10.12.2 Company Snapshot

10.12.3 Financial Overview

10.12.4 Product Listing

10.12.5 Entropy

10.13 Meril Life Sciences

10.13.1 Company Overview

10.13.2 Company Snapshot

10.13.3 Financial Overview

10.13.4 Product Listing

10.13.5 Entropy

10.14 Beijing Balance Medical Technology Co.

10.14.1 Company Overview

10.14.2 Company Snapshot

10.14.3 Financial Overview

10.14.4 Product Listing

10.14.5 Entropy

10.15 Venus Medtech

10.15.1 Company Overview

10.15.2 Company Snapshot

10.15.3 Financial Overview

10.15.4 Product Listing

10.15.5 Entropy

11. KOL Views

12. Project Approach

13. About the Publisher

14. Disclaimer

List of Tables

Table 1: Tissue Heart Valves Market in Global (2023-2034)

Table 2: Tissue Heart Valves Market in Global by Type (2023-2034)

Table 3: Tissue Heart Valves Market in Global by Valve Position (2023-2034)

Table 4: Tissue Heart Valves Market in Global by End-Users (2023-2034)

Table 5: Tissue Heart Valves Market in Global by Geography (2023-2034)

Table 6: Tissue Heart Valves Market in North America (2023-2034)

Table 7: Tissue Heart Valves Market in the United States (2023-2034)

Table 8: Tissue Heart Valves Market in Canada (2023-2034)

Table 9: Tissue Heart Valves Market in Mexico (2023-2034)

Table 10: Tissue Heart Valves Market in Europe (2023-2034)

Table 11: Tissue Heart Valves Market in France (2023-2034)

Table 12: Tissue Heart Valves Market in Germany (2023-2034)

Table 13: Tissue Heart Valves Market in United Kingdom (2023-2034)

Table 14: Tissue Heart Valves Market in Italy (2023-2034)

Table 15: Tissue Heart Valves Market in Spain (2023-2034)

Table 16: Tissue Heart Valves Market in the Rest of Europe (2023-2034)

Table 17: Tissue Heart Valves Market in Asia-Pacific (2023-2034)

Table 18: Tissue Heart Valves Market in China (2023-2034)

Table 19: Tissue Heart Valves Market in Japan (2023-2034)

Table 20: Tissue Heart Valves Market in India (2023-2034)

Table 21: Tissue Heart Valves Market in Australia (2023-2034)

Table 22: Tissue Heart Valves Market in South Korea (2023-2034)

Table 23: Tissue Heart Valves Market in Rest of Asia-Pacific (2023-2034)

Table 24: Tissue Heart Valves Market in the Rest of the World (2023-2034)

Table 25: Tissue Heart Valves Market in the Middle East (2023-2034)

Table 26: Tissue Heart Valves Market in Africa (2023-2034)

Table 27: Tissue Heart Valves Market in South America (2023-2034)

Table 28: Competitive Landscape

Table 29: Startup Funding & Investment Trends

List of Figures

Figure 1: Tissue Heart Valves Market Drivers

Figure 2: Tissue Heart Valves Market Restraints

Figure 3: Tissue Heart Valves Market Opportunities

Figure 4: AI-Powered Innovations in Tissue Heart Valves Market

Figure 5: US Tariff Impact on Tissue Heart Valves Market

Figure 6: Regulatory Analysis (US, EU, Japan, China)

Figure 7: Porter's Five Forces Analysis

Figure 8: Competitive Analysis

Figure 9: Tissue Heart Valves Market in Global (2023-2034)

Figure 10: Tissue Heart Valves Market in Global by Type (2023-2034)

Figure 11: Tissue Heart Valves Market in Global by Valve Position (2023-2034)

Figure 12: Tissue Heart Valves Market in Global by End-Users (2023-2034)

Figure 13: Tissue Heart Valves Market in Global by Geography (2023-2034)

Figure 14: Tissue Heart Valves Market in North America (2023-2034)

Figure 15: Tissue Heart Valves Market in the United States (2023-2034)

Figure 16: Tissue Heart Valves Market in Canada (2023-2034)

Figure 17: Tissue Heart Valves Market in Mexico (2023-2034)

Figure 18: Tissue Heart Valves Market in Europe (2023-2034)

Figure 19: Tissue Heart Valves Market in France (2023-2034)

Figure 20: Tissue Heart Valves Market in Germany (2023-2034)

Figure 21: Tissue Heart Valves Market in United Kingdom (2023-2034)

Figure 22: Tissue Heart Valves Market in Italy (2023-2034)

Figure 23: Tissue Heart Valves Market in Spain (2023-2034)

Figure 24: Tissue Heart Valves Market in the Rest of Europe (2023-2034)

Figure 25: Tissue Heart Valves Market in Asia-Pacific (2023-2034)

Figure 26: Tissue Heart Valves Market in China (2023-2034)

Figure 27: Tissue Heart Valves Market in Japan (2023-2034)

Figure 28: Tissue Heart Valves Market in India (2023-2034)

Figure 29: Tissue Heart Valves Market in Australia (2023-2034)

Figure 30: Tissue Heart Valves Market in South Korea (2023-2034)

Figure 31: Tissue Heart Valves Market in Rest of Asia-Pacific (2023-2034)

Figure 32: Tissue Heart Valves Market in the Rest of the World (2023-2034)

Figure 33: Tissue Heart Valves Market in the Middle East (2023-2034)

Figure 34: Tissue Heart Valves Market in Africa (2023-2034)

Figure 35: Tissue Heart Valves Market in South America (2023-2034)

Figure 36: Competitive Landscape

Figure 37: Startup Funding & Investment Trends

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/pumgz4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.